Bahrain has approved the Pfizer COVID-19 vaccine for emergency use for children aged between 5 and 11 years, the government media office said on Tuesday.
The decision came after a study involving 3,100 children aged between 5 and 11 were administered with the vaccine found it to be 90.7 per cent effecting in that age group, said the statement, citing the National Health Regulatory Authority.
None of the children involved in the study showed severe side effects, it added.
Bahrain will be supplied with doses from the manufacturer for the 5-11 age group from the start of 2022, it said.
Israel-Iran battle escalates, civilians urged to evacuate target areas
Harvard to urge judge to bar Trump from closing doors for international students
US police arrest suspect in Minnesota lawmakers' shooting
Three hikers killed by lightning strike in Austrian Alps
Trump calls for expanded deportation efforts of people illegally in US
Israel and Iran strike at each other in new wave of attacks
2 killed, several swept away after bridge collapses in India's Pune
Gunman who shot 2 US lawmakers still at large as manhunt continues
